BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 15753989)

  • 1. Overexpression of Endothelin-A-receptor in breast cancer: regulation by estradiol and cobalt-chloride induced hypoxia.
    Wülfing P; Götte M; Sonntag B; Kersting C; Schmidt H; Wülfing C; Buerger H; Greb R; Böcker W; Kiesel L
    Int J Oncol; 2005 Apr; 26(4):951-60. PubMed ID: 15753989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 17 beta-estradiol-regulated expression of protein tyrosine phosphatase gamma gene in cultured human normal breast and breast cancer cells.
    Zheng J; Kulp SK; Zhang Y; Sugimoto Y; Dayton MA; Govindan MV; Brueggemeier RW; Lin YC
    Anticancer Res; 2000; 20(1A):11-9. PubMed ID: 10769629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression and prognostic relevance of endothelin-B receptor in vulvar cancer.
    Eltze E; Bertolin M; Korsching E; Wülfing P; Maggino T; Lellé R
    Oncol Rep; 2007 Aug; 18(2):305-11. PubMed ID: 17611649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endothelin-1, Endothelin-A- and Endothelin-B-receptor expression in preinvasive and invasive breast disease.
    Wülfing P; Diallo R; Kersting C; Wülfing C; Poremba C; Greb RR; Böcker W; Kiesel L
    Oncol Rep; 2004 Apr; 11(4):791-6. PubMed ID: 15010874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of endothelin-1 and endothelin-A and -B receptors in invasive bladder cancer.
    Wülfing C; Eltze E; Piechota H; Abol-Enein H; Wülfing P; Bode ME; Hertle L; Sievert KD
    Oncol Rep; 2005 Feb; 13(2):223-8. PubMed ID: 15643502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 17Beta-estradiol induces down-regulation of Cap43/NDRG1/Drg-1, a putative differentiation-related and metastasis suppressor gene, in human breast cancer cells.
    Fotovati A; Fujii T; Yamaguchi M; Kage M; Shirouzu K; Oie S; Basaki Y; Ono M; Yamana H; Kuwano M
    Clin Cancer Res; 2006 May; 12(10):3010-8. PubMed ID: 16707596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imbalance between expression of endothelin receptors A and B in terminal liver cirrhosis due to hepatitis C viral infection: immunohistochemical study of autopsy cases.
    Kitamura Y; Hayashi K
    J Gastroenterol Hepatol; 2008 Aug; 23(8 Pt 2):e451-6. PubMed ID: 17565586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered endothelin receptor subtypes in colorectal cancer.
    Hoosein MM; Dashwood MR; Dawas K; Ali HM; Grant K; Savage F; Taylor I; Loizidou M
    Eur J Gastroenterol Hepatol; 2007 Sep; 19(9):775-82. PubMed ID: 17700263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Epidermal growth factor up-regulates the mRNA expression of endothelin-1 and its receptors in prostate cancer PC-3 cell lines].
    Jia RP; Jiang YF; Xu LW; Wang SK; Wang ZZ; Li WC; He BS
    Zhonghua Nan Ke Xue; 2008 Jan; 14(1):15-9. PubMed ID: 18297804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of the Endothelin-axis in the different histologic subtypes of renal cell carcinoma: a tissue microarray analysis.
    Herrmann E; Eltze E; Bierer S; Bogemann M; Brinkmann OA; Balnowair H; Hertle L; Wulfing C
    Oncol Rep; 2007 Feb; 17(2):275-80. PubMed ID: 17203161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of caveolin-1 and -2 in cell lines and in human samples of inflammatory breast cancer.
    Van den Eynden GG; Van Laere SJ; Van der Auwera I; Merajver SD; Van Marck EA; van Dam P; Vermeulen PB; Dirix LY; van Golen KL
    Breast Cancer Res Treat; 2006 Feb; 95(3):219-28. PubMed ID: 16244790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Contribution of endothelin and its receptors to ouabain-induced hypertension in rats].
    Jiang X; Guo N; Lü ZR
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Sep; 26(9):1297-300. PubMed ID: 16982439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The endothelin-1 receptor-mediated pathway is not involved in the endothelin-1-induced defenestration of liver sinusoidal endothelial cells.
    Yokomori H; Yoshimura K; Ohshima S; Nagai T; Fujimaki K; Nomura M; Oda M; Hibi T
    Liver Int; 2006 Dec; 26(10):1268-76. PubMed ID: 17105593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction between endothelin and angiotensin II in the up-regulation of vasopressin messenger RNA in the inner medullary collecting duct of the rat.
    Wang MH; Fok A; Huang MH; Wong NL
    Metabolism; 2007 Oct; 56(10):1372-6. PubMed ID: 17884447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TIMP-1 overexpression promotes tumorigenesis of MDA-MB-231 breast cancer cells and alters expression of a subset of cancer promoting genes in vivo distinct from those observed in vitro.
    Bigelow RL; Williams BJ; Carroll JL; Daves LK; Cardelli JA
    Breast Cancer Res Treat; 2009 Sep; 117(1):31-44. PubMed ID: 18787947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of vitamin D receptor expression via estrogen-induced activation of the ERK 1/2 signaling pathway in colon and breast cancer cells.
    Gilad LA; Bresler T; Gnainsky J; Smirnoff P; Schwartz B
    J Endocrinol; 2005 Jun; 185(3):577-92. PubMed ID: 15930183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aberrant expression of novel and previously described cell membrane markers in human breast cancer cell lines and tumors.
    Huang H; Groth J; Sossey-Alaoui K; Hawthorn L; Beall S; Geradts J
    Clin Cancer Res; 2005 Jun; 11(12):4357-64. PubMed ID: 15958618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Down-regulation and growth inhibitory role of C/EBPalpha in breast cancer.
    Gery S; Tanosaki S; Bose S; Bose N; Vadgama J; Koeffler HP
    Clin Cancer Res; 2005 May; 11(9):3184-90. PubMed ID: 15867211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rationale for sequential tamoxifen and anticancer drugs in adjuvant setting for patients with node- and receptor-positive breast cancer.
    Kim R; Tanabe K; Emi M; Uchida Y; Osaki A; Toge T
    Int J Oncol; 2005 Apr; 26(4):1025-31. PubMed ID: 15753998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcriptional deregulation of VEGF, FGF2, TGF-beta1, 2, 3 and cognate receptors in breast tumorigenesis.
    Soufla G; Porichis F; Sourvinos G; Vassilaros S; Spandidos DA
    Cancer Lett; 2006 Apr; 235(1):100-13. PubMed ID: 15949894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.